How to Build Your CAR-T Program with Carlos de Lima, MD
By Leah Sherwood - Last Updated: November 16, 2022Carlos de Lima, MD, stopped by the Blood Cancers Today video booth at the 2022 SOHO Annual Meeting and gave some advice on how to build a chimeric antigen receptor (CAR)-T program.
Advertisement
Advertisement
Related Posts
New data on immune thrombocytopenia were most prominent but Meeting coverage ranged over several forms of the disease.
Melody Smith, MD, MS, shares data on burnout in hematologist oncologists, why it occurs, and how to prevent it.
Cema-cel is feasible and can induce durable responses in patients with LBCL, achieving an ORR of 58% and a CR rate of 42%.
A panel moderated by Neil Love, MD, explored clinical data to assess these treatment approaches for the various types of NHL.
Real-world data shows evolving treatment strategies and clinical decision-making.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.